RECURSION PHARMACEUTICALS IN shareholders Q1 2023

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 158 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.9%.

RECURSION PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
STATE STREET CORP 6,372,515$42,504,6750.00%
MILLENNIUM MANAGEMENT LLC 646,610$4,3130.00%
BlackRock Inc. 10,631,857$70,914,4870.00%
VANGUARD GROUP INC 10,933,584$72,927,0050.00%
New Millennium Group LLC 275$1,8340.00%
Centiva Capital, LP 13,618$90,8320.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 983,939$6,562,8730.00%
Russell Investments Group, Ltd. 131,956$880,1460.00%
ExodusPoint Capital Management, LP 31,137$2080.00%
NORTHERN TRUST CORP 1,155,777$7,709,0320.00%
Skandinaviska Enskilda Banken AB (publ) 48,200$3210.00%
RHUMBLINE ADVISERS 209,878$1,4000.00%
GEODE CAPITAL MANAGEMENT, LLC 2,743,484$18,299,0450.00%
Slow Capital, Inc. 1,400$9,3380.00%
DIMENSIONAL FUND ADVISORS LP 697,285$4,650,8910.00%
STRS OHIO 62,100$4140.00%
DekaBank Deutsche Girozentrale 60,000$3870.00%
SIGNATUREFD, LLC 4,250$28,3480.00%
STATE OF WISCONSIN INVESTMENT BOARD 50,311$335,5740.00%
Citadel Advisors 605,515$4,038,7850.00%
External links

This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q1 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.